Rocket Pharmaceuticals in-27RCKTWPreferred / convertible
13F holders, Q2 2026 (June 30)11holders +1
2new positions
1sold out
1famous investor
$0.08avg. 13F price*
At the end of Q2 2026, 11 institutions reported holding Rocket Pharmaceuticals in-27 (RCKTW) in their 13F filings, up 1 from Q1 2026. 2 opened new positions and 1 sold out. The largest holders were Boothbay Fund Management, LLC ($126K), Citadel Advisors ($2K) and Sio Capital Management, LLC ($1K). One famous investor held it Ken Griffin ( of Citadel Advisors's portfolio).
- Company
- Rocket Pharmaceuticals in-27
- CUSIP
- 77313F114
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $49 |
| Exits | 1 | $84 |
All 13F filers, Q1 2026 → Q2 2026: 571 shares bought and 3,981 shares sold, net −3,410 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 11 holders
| Boothbay Fund Management, LLC | — | No change | 36,912 | $126K |
| Citadel Advisors | — | Add +0.1% | 310,370 | $2K |
| Sio Capital Management, LLC | — | No change | 400,000 | $1K |
| Walleye Capital LLC | — | No change | 284,345 | $1K |
| RTW Investments, LP | — | No change | 350,000 | $1K |
| LMR Partners LLP | — | No change | 75,731 | $364 |
| Silverarc Capital Management, LLC | — | No change | 104,828 | $356 |
| Affinity Asset Advisors, LLC | — | No change | 75,000 | $278 |
| Toronto Dominion Bank | — | New | 99 | $49 |
| Ancora Advisors LLC | — | No change | 6,000 | $22 |
| Clear Street Group Inc. | — | New | 99 | $0 |
"% of holder's portfolio" is RCKTW's weight in each manager's 13F, not the share of Rocket Pharmaceuticals in-27 the manager owns.